| Name | Levodopa-Induced Dyskinesia Management — MDS 2026 |
| Summary | Comprehensive coverage of levodopa-induced dyskinesia (LID) management strategies presented at MDS 2026, including pharmacological approaches, surgical interventions, and emerging therapies |